• Thermo Fisher Scientific's board authorized a new repurchase program for up to $5 billion of common stock.
• The program replaces the existing authorization, which had $1 billion remaining.
• The authorization has no expiration date. Repurchases may occur in the open market or through negotiated transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611051715BIZWIRE_USPR_____20261105_BW742300) on November 05, 2026, and is solely responsible for the information contained therein.